<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        50-539-11
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2011
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        GLIDE 1MG TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        GLIMEPIRIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        10.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DEEF PHARMACEUTICAL INDUSTRIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DEEF PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 479]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            DEEF MARKITING COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DEEF PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A10BB12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Glide</strong> is oral tablets that belongs to blood glucose lowering agents ( sulfonylurea class).</p><p><strong>Glide</strong> stimulates the release of insulin from functioning pancreatic beta cells; in addition leads to increased sensitivity of peripheral tissues to insulin.</p><p><strong>Glide</strong> is indicated to lower blood glucose in patients with noninsulin-dependent diabetes mellitus (NIDDM).</p><p><strong>Glide</strong> may be used for patients who do not respond to treatment with diet and exercise.</p><p><strong>Glide</strong> is used with metformin in cases that do not respond to each one alone.</p><p><strong>Glide</strong> is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycemia cannot be controlled by oral hypoglycemic agent alone</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>a. Don&rsquo;t take Glide and tell your physician if:&nbsp;</p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are allergic (hypersensitive) to glimepiride or any of the other ingredients of the product.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have insulin dependent diabetes.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are Diabetic ketoacidosis, in this condition treatment should be with insulin.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have&nbsp; a diabetic coma</p><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have severe renal problems</p><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have severe hepatic problems.</p><p>&nbsp;</p><p>b. Take special care with Glide:</p><p>Check with your physician or pharmacist before taking Glide if:</p><p>&bull; You recently have recovered from an operation, infections,&nbsp; injury, with fever, or from other stress forms, inform your physician&nbsp; as brief change of treatment may be necessary.</p><p>&bull; You have severe hepatic or renal problems.</p><p>If you are not sure if any of these apply to you, ask your physician or pharmacist before taking Glide.</p><p>Lowering of the haemoglobin level and haemolytic anemia may happen in patients missing the</p><p>enzyme glucose-6-phosphate dehydrogenase.</p><p>The information available on the use of Glide&nbsp; in population below 18 years is limited, therefore, its use in those patients is not recommended.</p><p>&nbsp;</p><p>Important information about low blood glucose</p><p>When you take Glide, you may get low blood glucose.</p><p>Please see below for additional information about low blood glucose, its signs and treatment.</p><p>Following factors may increase the risk of you getting low blood glucose:</p><p>&bull; Malnutrition, irregular meal time, missed or late meal or period of fasting</p><p>&bull; Changes to your diet habits.</p><p>&bull; Taking more Glide than needed</p><p>&bull; Having renal problems.</p><p>&bull; Having severe hepatic disease</p><p>&bull; If you suffer from particular disorders of the thyroid gland, of the pituitary gland or adrenal cortex.</p><p>&bull; If you increase your physical activity and you don&#39;t take enough food or you eat low- carbohydrate meals than normal.</p><p>&bull; Taking certain medicines.</p><p>&nbsp;</p><p>Signs of low blood glucose include:</p><p>&bull; Hunger pangs, headache, nausea, vomiting, sluggishness, sleepiness, problems sleeping, restlessness, aggression, problems with concentration, reduced alertness and reaction time, depression, confusion, problems with your speech and sight, slurred speech, shakiness, partial paralysis, dizziness, helplessness</p><p>&nbsp;</p><p>The following signs may also occur: sweating, clammy skin, anxiety, fast or increased heart beat, high blood pressure, and awareness of your heart beat, sudden strong pain in the breast that may radiate into neighboring areas (angina pectoris and cardiac arrhythmias)</p><p>&nbsp;</p><p>If blood glucose levels continue to drop you may suffer from considerable confusion (delirium), develop fits, lose self control, breathing may be shallow and your heart beat slows down, you may fall into unconsciousness. The clinical picture of a severe reduced blood glucose level may resemble that of a stroke.</p><p>&nbsp;</p><p>Treating low blood glucose:</p><p>In most cases the signs of lowered blood glucose disappear very quickly when you administer any form of glucose, e.g. sucrose cubes, sweet juice, sweetened tea.</p><p>&nbsp;</p><p>You should therefore always carry&nbsp; some form of glucose with you (e.g. sucrose cubes). Remember that artificial sweeteners are not useful.</p><p>&nbsp;</p><p>Please contact your physician or go to hospital if administered sucrose does not help or if the symptoms return.</p><p><strong>&nbsp;</strong></p><p>Laboratory Tests</p><p>The level of glucose in your blood or urine should be checked regularly.</p><p>&nbsp;Your physician may also take blood tests to monitor your blood cell levels and hepatic function.</p><p>&nbsp;</p><p>c-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking other medicaments</p><p>Please tell your physician or pharmacist if you are taking or have recently taken any other medicaments, including medicaments obtained without a prescription.</p><p>Your physician may wish to change your dose of Glide if you are taking other medicaments, which may weaken or strengthen the effect of Glide on the level of glucose in your blood.</p><p>&nbsp;</p><p>The following medicaments may augment blood glucose lowering effect of Glide. This may cause risk of low blood glucose:</p><p>Other medicaments to treat diabetes mellitus (such as insulin or metformin), Medicaments to treat pain and inflammation (phenylbutazone, azopropazone, oxyphenbutazone, aspirin-like medicaments), Medicaments to treat urinary tract infections (e.g. some long acting sulfonamides), Medicaments to treat fungal and bacterial infections (tetracyclines, chloramphenicol, fluconazole, miconazole, quinolones, clarithromycin), &nbsp;Medicaments to inhibit blood clotting (e.g. warfarin), &nbsp;Medicaments supporting muscle build up (anabolics), Medicaments used for male sex hormone replacement therapy, &nbsp;Medicaments to treat depression (fluoxetine, MAO-inhibitors) , &nbsp;Medicines that treat&nbsp; high blood cholesterol level (fibrates), Medicines that treat&nbsp; high blood pressure (ACE inhibitors), Anti-arrhythmic drugs (disopyramide), Gout drugs (allopurinol, probenecid, sulfinpyrazone), Antineoplastic drugs (cyclophosphamide, ifosfamide, trofosfamide), Drugs used to reduce weight (fenfluramine), High dose intravenous infusion of pentoxifylline, Tritoqualine and Sympatholytics drugs</p><p>&nbsp;</p><p>The following medicines may decrease the blood sugar lowering effect of Glide which can result in a hyperglycaemia (high blood sugar level):</p><p>Female sex hormones, thiazide diuretics, medicines used to stimulate the thyroid gland , Glucocorticoids, chlorpromazine , phenothiazine derivatives, adrenaline , sympathomimetics, nicotinic acid , prolonged use of laxatives, &nbsp;Phenytoin, Barbiturates, azetazolamide, diazoxide, rifampicin, glucagon.</p><p>&nbsp;</p><p>The following drugs may potentiate or diminish the blood glucose lowering effect of Glide, as these drugs may cover the hypoglycaemia signs, so special care shall be considered when administering these drugs.:</p><p>H2 antagonists, drugs for high blood pressure or heart failure such as beta-blockers, clonidine, guanethidine and reserpine.</p><p>&nbsp;</p><p>Glide may either increase or weaken the effects of the coumarin derivatives such as warfarin)</p><p>&nbsp;</p><p>d-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking Glide with food and drink</p><p>Alcoholic beverage administration may augment or reduce&nbsp; the blood glucose lowering action of Glide in an unpredictable way.</p><p>&nbsp;</p><p>e-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pregnancy and breast-feeding</p><p>Pregnancy</p><p>Pregnancy Risk Factor C</p><p>Glide should not be taken during pregnancy.</p><p>Tell your physician if you are, you think you might be, or are planning to become pregnant.</p><p><strong>&nbsp;</strong></p><p>Breast feeding</p><p>Glide may pass into breast milk. Glide should not be taken during breast feeding.</p><p>Ask your physician or pharmacist for advice before taking any medicine.</p><p>&nbsp;</p><p>Driving and using machine</p><p>Your ability to concentrate or react may be altered or if you develop visual troubles as a result of such conditions. Take in consideration that you may endanger yourself or others (e.g. when driving a car or using machines). You should ask your physician whether you can drive a car if you:</p><p>&bull; Have frequent episodes of low blood glucose,</p><p>&bull; Have fewer or no warning signals of hypoglycemia</p><p>&nbsp;</p><p>Important information about some of the ingredients of Glide</p><p>Glide contains lactose. If you have lactose intolerance, inform your physician.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>3. How to take Glide</strong></p><p>Always take Glide exactly as your physician has instructed you. You should check with your physician or pharmacist if you are not sure.</p><p><strong>&nbsp;</strong></p><p>Taking this medicament</p><p>&bull; Take this medicament orally, just before or with the first main meal of the day (usually breakfast). If you do not have breakfast you should take the product on schedule as given by your physician.</p><p>&nbsp;It is important not to miss out any meal when you are on Glide</p><p>&bull; Swallow the tablets whole with at least 100 ml water.</p><p>Do not crush or chew the tablets.</p><p><strong>&nbsp;</strong></p><p>How much to take</p><p>The dose of Glide depends on your needs, condition and results of blood and urine glucose tests and is determined by your physician. Do not administer&nbsp; more tablets than your physician has prescribed.</p><p>&bull; The usual starting dose is one Glide 1 mg tablet once a day</p><p>&bull; If necessary, your physician may increase the dose after each 7 -14 days of treatment</p><p>&bull; The maximum recommended dose is 6 mg Glide per day.</p><p>&bull; A combination therapy of Glide plus metformin or of Glide plus insulin may be started. In such situation&nbsp; your physician will decide the proper doses of Glide, metformin or insulin individually for you</p><p>&bull; Your dose of Glide may need to be re-calculated&nbsp; if the following changes occur;&nbsp; weight , lifestyle, daily stress.</p><p>Please discuss with your physician if any of these situations apply to you.</p><p>&bull; If you feel the effect of your medicament is very weak or very strong do not change the dose yourself, but ask your physician.</p><p>a-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you take more Glide than you should</p><p>If you happen to have taken too much Glide or an additional dose there is a danger of hypoglycemia and therefore you should instantly consume enough glucose (e.g. a small bar of sucrose cubes, sweet juice, sweetened tea) and inform a physician immediately.</p><p>When treating hypoglycemia due to unintended ingestion in children, the quantity of glucose given must be carefully controlled to avoid the possibility of producing hazardous hyperglycemia. Persons in a state of unconsciousness must not be given food or drink.</p><p>Since the state of hypoglycemia may last for sometime it is very important that the patient is carefully observed&nbsp; until there is no more danger. Admission into hospital may be required.</p><p>Severe cases of hypoglycemia accompanied by loss of consciousness and coma are cases of medical emergency requiring immediate medical treatment and admission into hospital.</p><p><strong>&nbsp;</strong></p><p>b-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you forget to take Glide</p><p>If you forget to take a dose, do not take a double dose to make up for forgotten doses.</p><p><strong>&nbsp;</strong></p><p>c-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you stop taking Glide</p><p>If you interrupt or stop the treatment you should be aware that the desired blood glucose lowering effect is not achieved or that the disease may get worse again. Keep taking Glide until your physician tells you to stop.</p><p>If you have any further inquiries on the use of Glide, ask your physician or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>4. Possible Side Effects:</strong></p><p>Like all medicaments, Glide can cause side effects, although not everybody gets them.</p><p>Tell your physician immediately if you experience any of the following symptoms:</p><p>&bull; Allergic reactions which may develop into serious reactions with difficulty in breathing, fall in blood pressure and sometimes progressing to shock</p><p>&bull; Abnormal hepatic function including symptoms of&nbsp; jaundice, problems with the bile flow (cholestasis), hepatitis or hepatic failure.</p><p>&bull; Severe hypoglycemia including loss of consciousness, seizures or coma.</p><p>Some patients experienced the following side effects whilst taking glimepiride:</p><p>Rare side effects (&gt; 1 in 10,000 and &lt; 1 in 1000)</p><p>&bull; low blood glucose</p><p>&bull; Decrease in the number of blood cells;&nbsp; platelets,&nbsp; White blood cells,&nbsp; Red blood cells</p><p>Very rare side effects (affects &lt; 1 in 10,000)</p><p>&bull; Allergic reactions</p><p>&bull; Abnormal hepatic function including jaundice, cholestasis, hepatitis or hepatic failure.</p><p>&bull; Feeling or being sick, diarrhea, feeling full or bloated, and abdominal pain</p><p>&bull; Decrease in the amount of sodium level in your blood (shown by blood tests)</p><p>Other side effects include:</p><p>&bull; Skin&nbsp; Allergy , Some mild allergic reactions may develop into serious reactions with swallowing or breathing problems, swelling of your lips, throat or tongue.</p><p>&bull; Problems with your sight may occur when starting&nbsp; treatment with Glide. This is due to changes in blood glucose levels and should soon improve.</p><p>&bull; Increased hepatic enzymes.</p><p>&nbsp;</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your physician or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>5. How to store Glide :</strong></p><p>Keep out of the reach and sight of children.</p><p>Do not store above 30&deg;C.</p><p>Store in the original carton.</p><p>Do not use Glide after the expiry date which is stated on the carton and blisters, the expiry date refers to the last day of that month.</p><p>Do not use Glide if you notice any visible signs of deterioration.</p><p>Medicine should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>a-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Glide contains</p><p><strong>Glide 1 :</strong> Each tablet contains 1 mg of glimepiride.</p><p>The other ingredients are: lactose monohydrate, sodium starch glycolate , sodium lauryl sulfate, magnesium Stearate ,&nbsp; povidone and&nbsp; iron oxide red (E172).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                b-	What Glide looks like and contents of the pack
Glide 1 : Each tablet of Glide is pink oblong binotched and scored on both sides and engraved GI1 on one side, plain on the other side.
They are supplied in blister packs of 30 tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>DEEF Pharmaceutical Industries</p><p>Tel: 06 332 3333</p><p>Fax: 06 332 4444</p><p>e-mail: cust.care@deef.com</p><p>&nbsp;</p><p>For any information&nbsp; about this medicinal product, please contact the local representative of the marketing authorization holder:</p><p>DEEF Pharmaceutical Industries</p><p>Badaye&nbsp; Qassim&nbsp;&nbsp; Saudi Arabia</p><p>Tel: 06 332 3333</p><p>e-mail: cust.care@deef.com</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                 This leaflet was last updated in 06 -2011; version No. AI0082-01
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>1-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ماهو</strong><strong> </strong><strong>جلايد</strong><strong> </strong><strong>وما</strong><strong> </strong><strong>هي</strong><strong> </strong><strong>دواعي</strong><strong> </strong><strong>استعماله </strong><strong>.</strong></p><p dir="RTL">أقراص جلايد هي دواء لمعالجة داء السكري وتنتمي لمجموعة السلفونيل يوريا، جلايد يقوم باستحثاث إفراز الإنسولين من خلايا بيتا بالبنكرياس بالإضافة إلى أنه يقوم بزيادة حساسية الأنسجة الطرفية نحو الإنسولين .</p><p dir="RTL">جلايد يستخدم لخفض مستوى الجلوكوز بالدم في مرضى داء السكري غير المعتمدين على الإنسولين (النمط الثاني) .</p><p dir="RTL">جلايد قد يستخدم للمرضى الذين لا يستجيبون للعلاج بالحمية الغذائية&nbsp; و التمارين الرياضية&nbsp; .</p><p dir="RTL">جلايد يستخدم مع الميتفورمين في الحالات التي لا تستجيب لأي منهما بمفرده .</p><p dir="RTL">جلايد قد يستخدم مع الإنسولين لخفض الجلوكوز بالدم في المرضى الذين يعانون من ارتفاع مستوى الجلوكوز بالدم لمستويات لا تستطيع مضادات السكري الفموية خفضها .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>- قبل</strong><strong> </strong><strong>القيام</strong><strong> </strong><strong>بتناول</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>إستعمال</strong><strong> </strong><strong>جلايد </strong><strong>&nbsp;.</strong></p><p dir="RTL">أ&zwnj;-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تأخذ جلايد و أخبر طبيبك في الحالات التالية :</p><p dir="RTL">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية لمادة الجليمبيرايد أو أي من مكونات المستحضر الأخرى .</p><p dir="RTL">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من داء السكري المعتمد على الإنسولين ( النمط الأول ) .</p><p dir="RTL">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من الحماض الكيتوني السكري ، حيث أن هذه الحالة يجب معالجتها بالإنسولين .</p><p dir="RTL">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من إغماءة سكر .</p><p dir="RTL">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من قصور بوظائف الكلى .</p><p dir="RTL">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من قصور بوظائف الكبد .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ب&zwnj;-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الإحتياطات عند استعمال جلايد :</strong></p><p dir="RTL">راجع الطبيب أو الصيدلي قبل تناول جلايد في الحالات التالية :</p><p dir="RTL">&bull; إذا كنت في الآونة الأخيرة قد تعافيت من عملية جراحية ، أو التهابات ، وإصابة أو حمى ، أو أي شكل من أشكال الضغط الأخرى ، ويجب إبلاغ الطبيب المعالج حيث أن تغييرات مؤقتة على العلاج قد تكون ضرورية .</p><p dir="RTL">&bull; إذا كانت لديك مشاكل حادة بالكبد أو الكلى .</p><p dir="RTL">إذا لم تكن متأكدا مما إذا كان أي من هذه الحالات تنطبق عليك ، راجع الطبيب أو الصيدلي قبل تناول جلايد .</p><p dir="RTL">قد يحدث خفض من مستوى الهيموجلوبين بالدم وفقر الدم الانحلالي عند المرضى الذين يعانون من فقدان<br />إنزيم الجلوكوز 6 فوسفات الديهيدروجينيز.</p><p dir="RTL">المعلومات المتاحة عن استخدام جلايد في المرضى الذين تقل أعمارهم عن 18 سنة محدودة ، ولذلك لا ينصح باستخدامه في هؤلاء المرضى.</p><p dir="RTL">معلومات هامة حول انخفاض الجلوكوز بالدم</p><p dir="RTL">عندما تتعاطى جلايد قد يحدث&nbsp; انخفاض لجلوكوز الدم.</p><p dir="RTL">معلومات إضافية حول انخفاض الجلوكوز في الدم ، وعلامات انخفاضه والعلاج:</p><p dir="RTL">العوامل التالية قد تزيد من خطر حدوث انخفاض الجلوكوز في الدم :</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوء التغذية وعدم انتظام مواعيد تناول الوجبات ، و عدم تناول أو تأخير تناول الوجبات والصيام .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغييرات في العادات الغذائية الخاصة بك.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخذ أكثر مما يجب من جلايد .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل الكلى .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاضطرابات الكبدية الحادة .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض أو اعتلال بالغدة الدرقية أو الغدة النخامية أو قشرة الكظر .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالة زيادة النشاط البدني وعدم تناول ما يكفي من الطعام أو في حالة تناول وجبات منخفضة الكربوهيدرات .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول الأدوية الأخرى .</p><p dir="RTL">علامات انخفاض الجلوكوز بالدم تشمل ما يلي:</p><p dir="RTL">&nbsp;&nbsp;آلام الجوع والصداع والغثيان والقيء والخمول ، النعاس ، ومشاكل النوم ، والأرق ، والعدوانية ، مشاكل في التركيز ، وانخفاض اليقظة وفترة رد الفعل ، والاكتئاب ، والارتباك ، و ثقل اللسان ومشاكل في البصر والكلام ، والاهتزاز ، والشلل الجزئي ، دوخة ، والعجز.</p><p dir="RTL">كما قد تحدث الأعراض التالية :<strong><em> </em></strong>التعرق ، ندي الجلد ، والقلق ، أو زيادة سرعة ضربات القلب وارتفاع ضغط الدم ،&nbsp; وآلام قوية مفاجئة في الثدي التي يمكن أن تمتد للمناطق المجاورة (الذبحة الصدرية واضطرابات النظم القلبية) .</p><p dir="RTL">إذا استمرت مستويات الجلوكوز في الدم في الانخفاض فقد يحدث : هذيان ، وفقدان السيطرة على النفس ، وضحالة التنفس و تباطؤ ضربات القلب ، و قد تحدث غيبوبة. الأعراض السريرية للانخفاض الحاد لمستوى الجلوكوز بالدم تتشابه مع تلك الناتجة عن السكتة الدماغية .</p><p dir="RTL">علاج انخفاض الجلوكوز بالدم :</p><p dir="RTL">في معظم الحالات تختفي&nbsp; الأعراض بسرعة عند تناول الجلوكوز في أي صورة ، على سبيل المثال مكعبات السكر والعصير المحلى و والشاي المحلى. ولذلك يجب أن يحمل المريض دائماً مصدرا للجلوكوز (مثل مكعبات السكر). تذكر أن مواد التحلية الاصطناعية ليست مفيدة.</p><p dir="RTL">يرجى الاتصال بالطبيب أو الذهاب إلى المستشفى إذا لم يساعد تناول السكريات أو إذا عادت الأعراض .</p><p dir="RTL">الاختبارات المعملية:</p><p dir="RTL">ينبغي فحص مستوى الجلوكوز في الدم أو البول بانتظام .</p><p dir="RTL">قد يقوم الطبيب أيضاً بعمل&nbsp; اختبارات الدم لمراقبة مستويات خلايا الدم&nbsp; ووظائف الكبد .</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>ج - التداخلات الدوائية من أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية </strong></p><p dir="RTL">يجب&nbsp; إعلام الطبيب أو الصيدلي إذا كنت تأخذ أو أخذت في الآونة الأخيرة أي أدوية أخرى ، بما في ذلك الأدوية التي تصرف من دون وصفة طبية .</p><p dir="RTL">قد يرغب طبيبك في تغيير جرعة جلايد الخاصة بك إذا كنت تأخذ أدوية أخرى ، والتي قد تضعف أو تعزز تأثير جلايد على مستوى الجلوكوز في الدم .</p><p dir="RTL">الأدوية التالية قد تعزز التأثير الخافض للجلوكوز في الدم ، و قد يؤدي ذلك إلى مخاطر انخفاض الجلوكوز في الدم :</p><p dir="RTL">الأدوية الأخرى لعلاج داء السكري (مثل الإنسولين او ميتفورمين) ، أدوية علاج الألم والالتهاب (بيوتازون ، أزوبروبازون ، والأوكسي فينبيوتازون والأسبرين) ، أدوية علاج التهابات المسالك البولية (على سبيل المثال بعض السلفوناميدات طويلة المفعول) ، أدوية علاج الأمراض الفطرية والبكتيرية (التتراسيكلين ، فلوكونازول ، الكلورامفينيكول ، ميكونازول ، الكوينولونات ، كلاريثروميسين) ، أدوية منع تخثر الدم (مثل وارفارين) ، الأدوية التي تدعم بناء العضلات &nbsp;، الأدوية المستخدمة لتعويض الهرمون الذكري ، أدوية علاج الاكتئاب (فلوكستين ، مثبطات ماو) ، أدوية علاج إرتفاع الكوليسترول (الفيبرات ) ، أدوية معالجة ضغط الدم المرتفع ( مثبطات إسي ) ، أدوية معالجة &nbsp;إضطراب ضربات القلب (دايسبراميد) ، أدوية النقرس (اللوبيرينول و بروبانسيد و سالفينبيرازون ) ، أدوية السرطان (سيكلوفوسفاميد ، أيفوسفاميد ، تروفوسفاميد) ، أدوية إنقاص الوزن ( فينفلورامين) ، الجرعات العالية للحقن من البنتوكسيفللين ، ترايتوكوالين ، الأدوية الداحضة الودي</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية التالية قد تضعف التأثير الخافض للجلوكوز في الدم ، و قد يؤدي ذلك إلى مخاطر إرتفاع &nbsp;الجلوكوز في الدم :</p><p dir="RTL">&nbsp;الهرمونات الأنثوية ، مدرات البول من نوع ثيازيد ، الأدوية المنشطة للغدة الدرقية ، الإستيرويدات الحلقية ، كلوروبرومازين ، مشتقات فينوثيازين ، الأدرينالين ، مستحثات العصب الودي ، حمض النيكوتينيك ، الإستعمال الطويل للملينات ، الفينيتوين ، الباربيتيورات ، أزيتازولاميد ، ديازوكسيد ، ريفامبسين&nbsp; و جلوكاجون .</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية التالية قد تعزز أو تضعف التأثير الخافض للجلوكوز في الدم ، هذه الأدوية قد تغطي على علامات نقص السكر ، لذا يجب أخذ الحيطة&nbsp; عند تعاطي هذه الأدوية :</p><p dir="RTL">مضادات مستقبلات هـ2 ، أدوية معالجة ضغط الدم المرتفع مثل مضادات مستقبلات بيتا&nbsp; و كلونيدين و جوانثيدين و ريسيربين .</p><p dir="RTL">&nbsp;</p><p dir="RTL">جلايد قد بعزز أو يضعف من تأثير مشتقات الكيومارين مثل وارفارين .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>د - تعاطي جلايد مع الطعام والشراب</strong></p><p dir="RTL">إن تعاطي المشروبات الكحولية قد يؤدي لتعزيز أو إضعاف تأثير جلايد على خفض مستوى السكر في الدم بطريقة لا يمكن التنبؤ بها .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>هـ - الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">الحمل</p><p dir="RTL">معامل الحمل لجلايد هو ج .</p><p dir="RTL">لا ينبغي أن يؤخذ جلايد أثناء فترة الحمل .</p><p dir="RTL">أخبري طبيبك إذا كنتي ، أو كنتي تعتقدين أنك قد تكوني ، أو بصدد التخطيط للحمل .</p><p dir="RTL">الرضاعة<br />جليمبيرايد قد يفرز في حليب الثدي لذا&nbsp; لا ينبغي أن يؤخذ جلايد أثناء الرضاعة الطبيعية .</p><p dir="RTL">إسألي طبيبك أو الصيدلي للحصول على المشورة قبل تناول أي دواء .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>و &ndash; تأثير جلايد على القيادة واستخدام الألات </strong></p><p dir="RTL">قد يحدث تغيير في قدرتك على التركيز أو زمن رد الفعل أو قد تحدث اضطرابات بصرية نتيجة لهذه الظروف. يجب الأخذ في الاعتبار أنه قد تعرض نفسك أو الغير للخطر (على سبيل المثال عند قيادة السيارة أو استخدام الآلات) .</p><p dir="RTL">&nbsp;يجب عليك أن تسأل الطبيب ما إذا كان يمكنك قيادة السيارة إذا كنت :</p><p dir="RTL">&bull;تعرضت لنوبات متكررة من انخفاض الجلوكوز في الدم .</p><p dir="RTL">&bull; تعاني من قلة أو عدم وجود علامات تحذيرية على انخفاض الجلوكوز في الدم .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ز - معلومات هامة حول بعض مكونات جلايد :</strong></p><p dir="RTL">تحتوي&nbsp; أقراص جلايد على اللاكتوز، إذا كنت تعاني من حالة اللاتحمل للاكتوز يجب إخبار طبيبك .</p><p>&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>3 - </strong><strong>طريقة</strong><strong> </strong><strong>إستخدام</strong><strong> </strong><strong>جلايد </strong><strong>.</strong></p><p dir="RTL">يجب الالتزام بتناول جرعات جلايد حسب وصف الطبيب المعالج ، في حال عدم التأكد من طريقة الاستعمال يجب مراجعة الطبيب أو الصيدلي .</p><p dir="RTL">استخدام هذا الدواء :</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يستخدم جلايد عن طريق التناول بالفم ، قبل تناول الوجبة الأساسية&nbsp; مباشرة أو أثناء تناولها ( عادة الفطور ) ، في حال عدم تناول فطور يجب تعاطي المستحضر على حسب المواعيد المعطاة بواسطة الطبيب .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من المهم عدم نسيان تناول الوجبات عند استخدام جلايد .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب بلع الأقراص بالكامل مع 100 مل ماء ، يجب عدم قضم الأقراص أو مضغها .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كيفية استخدام جلايد </strong></p><p dir="RTL">إن جرعة جلايد تعتمد على احتياجاتك ، ونتائج فحوصات مستوى الجلوكوز بالدم والبول ويتم تحديد الجرعات بواسطة طبيبك المعالج ، يجب عدم تعاطي جرعات أكثر مما وصفه الطبيب .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة&nbsp; الأولية المعتادة هي 1 ملجم يومياً .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن للطبيب زيادة الجرعة بعد 7 &ndash; 14 يوم من تناول العلاج في حالة الحاجة .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة القصوى الموصى بها هي 6 ملجم يومياً .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن إعطاء جلايد أقراص مع ميتفورمين أقراص&nbsp; أو مع الإنسولين ، وفي هذه الحالات يجب على الطبيب المعالج تحديد الجرعات الموصوفة لكل دواء .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تحتاج الجرعة الموصوفة إلى إعادة تقييم في الحالات التالية : تغيير نمط الحياة ، الوزن، تغير ضغوط الحياة اليومية ، يوصى بمناقشة هذه التغيرات مع الطبيب في حال حدوثها .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا شعرت بأن مفعول الدواء ضعيف جداً أو قوي جداً يجب مراجعة الطبيب ولكن لا يجب تغيير الجرعة تلقائياً .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أ&zwnj;-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الجرعات الزائدة من جلايد </strong></p><p dir="RTL">في حالة&nbsp; تناول جلايد أقراص أكثر من الجرعة الموصوفة&nbsp; فإن هناك خطورة من حدوث انخفاض بمستوى الجلوكوز بالدم ، لذا ينبغي تناول كمية من الجلوكوز على الفور ( مثل مكعبات السكر أو عصير محلى أو شاي محلى ) ويجب إخبار الطبيب على الفور .</p><p dir="RTL">عند معالجة انخفاض الجلوكوز في الدم لدى الأطفال نتيجة التعاطي غير المقصود للأقراص ، يجب تناول كمية محسوبة بعناية من الجلوكوز وذلك لتفادي حدوث زيادة في مستوى الجلوكوز بالدم وما يتبعها من مخاطر . يجب عدم إعطاء أي شراب أو طعام للأشخاص فاقدي الوعي .</p><p dir="RTL">بما أن حالات انخفاض مستوى الجلوكوز بالدم قد تستمر لبعض الوقت فإنه من المهم جداً ملاحظة المريض بعناية حتى لا تحدث مضاعفات خطيرة ، وقد يكون الملاحظة بالمستشفى مطلوبة .</p><p dir="RTL">الحالات الشديدة من نقص الجلوكوز بالدم المصحوبة بفقدان الوعي والغيبوبة هي&nbsp; من حالات الطوارئ الطبية التي تتطلب العلاج الطبي الفوري ودخول المستشفى.</p><p dir="RTL"><strong>ب&zwnj;-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>نسيان تناول جرعة جلايد</strong></p><p dir="RTL">عند نسيان جرعة جلايد ، يجب عدم تناول جرعة مضاعفة لتعويض الجرعة المنسية .</p><p dir="RTL"><strong>ج - التوقف عن تناول جلايد</strong></p><p dir="RTL">في حال التوقف عن تناول أقراص جلايد ، يجب أن تكون على علم بأن التأثير المطلوب من خفض نسبة الجلوكوز بالدم قد لا يتحقق ، أو أن الحالة المرضية قد تزداد سوءاً مرة أخرى ، يجب الاستمرار بتناول جلايد حتى يأمرك الطبيب بالتوقف .</p><p dir="RTL">إذا كان لديك أي استفسارات أخرى بشأن استخدام جلايد&nbsp; ، يجب مراجعة الطبيب المعالج أو الصيدلي .</p><p><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>-الآثار الجانبية المحتملة</strong></p><p dir="RTL">قد يسبب جلايد بعض الآثار الجانبية مثل غيره من الأدوية&nbsp; على الرغم من عدم حدوث كل الأعراض في كل المرضى .</p><p dir="RTL">يجب إعلام طبيبك فوراً في حال حدوث أي من الأعراض التالية :</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية والتي قد تتطور لتفاعلات خطيرة قد تكون مصحوبة بصعوبة في التنفس و انخفاض في ضغط الدم و قد تتطور لحدوث صدمة .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب في&nbsp; وظائف الكبد و يشمل العلامات التالية : اليرقان و ركود صفراوي و التهابات الكبد وقد يحدث قصور كبدي .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هبوط حاد بمستوى الجلوكوز بالدم&nbsp; وتشمل أعراضه : فقد الوعي أو تشنجات أو غيبوبة .</p><p dir="RTL">بعض المرضى قد حدثت لهم الأعراض الجانبية التالية عند تعاطي جليمبيرايد :</p><p dir="RTL">&nbsp; الآثار الجانبية النادرة (أعلى&nbsp; من 1 في 10000 و أقل&nbsp; من 1 في 1000)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض الجلوكوز بالدم .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص في عدد خلايا الدم الحمراء والبيضاء والصفائح الدموية .</p><p dir="RTL">&nbsp; الآثار الجانبية النادرة&nbsp; جداً (أقل من 1 في 10000)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب في&nbsp; وظائف الكبد و يشمل العلامات التالية : اليرقان و ركود صفراوي و التهابات الكبد وقد يحدث قصور كبدي .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإحساس بالإرهاق أو المرض ، الإسهال ، الإحساس بالامتلاء وألم بالبطن .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص مستوى الصوديوم بالدم ( يكشف بواسطة اختبارات الدم ) .</p><p dir="RTL">الآثار الجانبية الأخرى تشمل :</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية ، والتي قد تتطور لتفاعلات خطيرة قد تكون مصحوبة بصعوبة في التنفس و التعرق و تورم الشفاة&nbsp; أو الزور&nbsp; أو اللسان .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تحدث مشاكل بالنظر عند بداية العلاج ، وقد تعزى إلى تغير مستوى الجلوكوز بالدم وتقل مع الوقت .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستويات إنزيمات الكبد بالدم .</p><p dir="RTL">في حال حدوث أي من&nbsp; الآثار الجانبية ، أو إذا لاحظت أي آثار جانبية غير مدرجة في هذه النشرة ، يرجى إخبار الطبيب أو الصيدلي .</p><p dir="RTL">&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>- ظروف حفظ جلايد</strong></p><p dir="RTL">يحفظ بعيدا عن متناول وبصر الأطفال .</p><p dir="RTL">لا يحفظ&nbsp; فوق 30 درجة مئوية .</p><p dir="RTL">يخزن&nbsp; في الكرتون الأصلي .</p><p dir="RTL">لا يستخدم&nbsp; بعد تاريخ انتهاء الصلاحية المنصوص على الكرتون و الشرائط&nbsp; ، تاريخ انتهاء الصلاحية&nbsp; يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تستخدم المستحضر إذا لاحظت وجود علامات واضحة على سوء حالة العبوة.</p><p dir="RTL">لا ينبغي أن يتم التخلص من الدواء عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي كيفية التخلص من الأدوية التي لم تعد مطلوبة ، ومن شأن هذه التدابير أن تساعد على حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>أ&zwnj;.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ماهي محتويات جلايد :</strong></p><p dir="RTL"><strong>جلايد 1 :</strong> يحتوي القرص على 1 ملجم من مادة الجليمبيرايد</p><p dir="RTL">المكونات الأخرى هي لاكتوز أحادي الماء و جليكولات النشا والصوديوم و كبريتات اللوريل والصوديوم و سترات الماغنسيوم و بوفيدون و أكسيد الحديديك الأحمر (إي 172)</p><p dir="RTL"><strong>جلايد 2 :</strong> يحتوي القرص على 2 ملجم من مادة الجليمبيرايد</p><p dir="RTL">المكونات الأخرى هي لاكتوز أحادي الماء و جليكولات النشا والصوديوم و كبريتات اللوريل والصوديوم و سترات الماغنسيوم و بوفيدون و أكسيد الحديديك الأصفر &nbsp;(إي 172) &nbsp;و إي 132</p><p dir="RTL"><strong>جلايد 3 :</strong> يحتوي القرص على 3 ملجم من مادة الجليمبيرايد</p><p dir="RTL">المكونات الأخرى هي لاكتوز أحادي الماء و جليكولات النشا والصوديوم و كبريتات اللوريل والصوديوم و سترات الماغنسيوم و بوفيدون و أكسيد الحديديك الأصفر &nbsp;(إي 172)</p><p dir="RTL"><strong>جلايد 4 :</strong> يحتوي القرص على 4 ملجم من مادة الجليمبيرايد</p><p dir="RTL">المكونات الأخرى هي لاكتوز أحادي الماء و جليكولات النشا والصوديوم و كبريتات اللوريل والصوديوم و سترات الماغنسيوم و بوفيدون و إي 132</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>أ&zwnj;.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ما هو الشكل الصيدلاني لجلايد ووصفه وحجم عبوته :</strong></p><p dir="RTL"><strong>جلايد 1 :</strong> قرص مستطيل وردي اللون ذو نتوءات جانبية ومحزز ومحفور على أحد سطحيه GI1 &nbsp;والسطح الأخر بدون حفر .</p><p dir="RTL">تحتوي العبوة على 3 شرائط&nbsp; بكل منها 10 أقراص .</p><p dir="RTL"><strong>جلايد 2 :</strong> قرص مستطيل أخضر اللون ذو نتوءات جانبية ومحزز ومحفور على أحد سطحيه GD2 &nbsp;والسطح الأخر بدون حفر .</p><p dir="RTL">تحتوي العبوة على 3 شرائط&nbsp; بكل منها 10 أقراص .</p><p dir="RTL"><strong>جلايد 3 :</strong> قرص مستطيل أصفر اللون ذو نتوءات جانبية ومحزز ومحفور على أحد سطحيه GI3 &nbsp;والسطح الأخر بدون حفر .</p><p dir="RTL">تحتوي العبوة على 3 شرائط&nbsp; بكل منها 10 أقراص .</p><p dir="RTL"><strong>جلايد 4 :</strong> قرص مستطيل أزرق &nbsp;اللون ذو نتوءات جانبية ومحزز ومحفور على أحد سطحيه GI4 &nbsp;والسطح الأخر بدون حفر .</p><p dir="RTL">تحتوي العبوة على 3 شرائط&nbsp; بكل منها 10 أقراص .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ج . اسم وعنوان مالك رخصة&nbsp; التسويق والمصنع :</strong></p><p dir="RTL">شركة ديف للصناعات الدوائية</p><p dir="RTL">هاتف : 063323333</p><p dir="RTL">فاكس :063324444</p><p dir="RTL">البريد الإلكتروني : cust.care@deef.com</p><p dir="RTL">لأي معلومات عن هذا المستحضر يرجى الإتصال بممثل المصنع :</p><p dir="RTL">شركة ديف للصناعات الدوائية</p><p dir="RTL">البدائع&nbsp; القصيم&nbsp;&nbsp;&nbsp; المملكة العربية السعودية</p><p dir="RTL">هاتف : 063323333</p><p dir="RTL">البريد الإلكتروني : cust.care@deef.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقة على هذه النشرة بتاريخ 06 – 2011 ، رقم الإصدار  AI0082-01
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Glide 1 Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 1 mg of glimepiride
Excipients are listed in point 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Uncoated tablet.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glimepiride is a sulfonylurea antidiabetic. It is given orally for the treatment of type 2 diabetes</p><p>mellitus when diet, physical activity and weight control alone are not adequate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The basis for successful management of diabetes is a proper diet, regular physical activity, as well as</p><p>routine checks of blood and urine. Tablets or insulin cannot compensate if the patient does not keep to</p><p>the recommended diet.</p><p>Initial doses is 1 mg daily.</p><p>For the different dosage regimens other strengths are existing.</p><p>If control is unsatisfactory the dosage should be modified, based on the glycaemic control, in a</p><p>stepwise manner with an interval of about 1 to 2 weeks between each step, to 2, 3 or 4 mg glimepiride</p><p>per day.</p><p>A dosage of more than 4 mg glimepiride per day gives acceptable results only in exceptional cases.</p><p>The highest suggested dose is 6 mg glimepiride per day.</p><p>In patients not adequately controlled with the highest daily dose of metformin, simultaneous</p><p>glimepiride therapy can be initiated.</p><p>While maintaining the metformin dose, the glimepiride therapy is initiated with a low dose, and is then</p><p>titrated up based on the desired level of control up to the maximum daily dose. The combination</p><p>therapy should be taken under close medical supervision.</p><p>In patients not adequately controlled with the maximum daily dose of Glide, simultaneous insulin</p><p>therapy can be started if required. While maintaining the glimepiride dose, insulin treatment is started</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>at low dose and increased depending on the desired level of metabolic control. The combination</p><p>therapy should be taken under close medical supervision.</p><p>Normally one daily dose of glimepiride is enough. It is advised that this dose be administered shortly</p><p>before or during a substantial breakfast or if none is taken - shortly before or during the first main</p><p>meal.</p><p>If a dose is missed, this should not be corrected by increasing the next dose.</p><p>Tablets should be swallowed completely without crushing or chewing with 100 ml liquid.</p><p>If a patient has a hypoglycaemic reaction on 1 mg glimepiride daily, this be a sign of that they can be</p><p>controlled by diet alone.</p><p>In the course of treatment, as an enhancement in control of diabetes is related with higher insulin</p><p>sensitivity, glimepiride requirements may decrease. To avoid hypoglycaemia timely dose reduction or</p><p>cessation of therapy must therefore be considered. Modification in dosage may also be required, if there</p><p>are changes in weight or life style of the patient, or other factors that increase the risk of hypo-or</p><p>hyperglycaemia.</p><p>Switch over from other oral hypoglycaemic agents to Glide:</p><p>A switch over from other oral hypoglycaemic agents to Glide can usually be done. For the switch over</p><p>to Glide the strength and the half-life of the previous drug has to be considered. In some cases,</p><p>especially in antidiabetics with a long half-life (e.g. chlorpropamide), a wash out period of a few days</p><p>is recommended in order to minimise the risk of hypoglycaemic reactions due to the additive effect.</p><p>The recommended starting dose is 1 mg glimepiride per day. Based on the response the glimepiride</p><p>dosage may be increased stepwise, as indicated earlier.</p><p>Switch over from Insulin to Glide</p><p>In exceptional cases, where type 2 diabetic patients are regulated on insulin, a changeover to Glide may</p><p>be recommended. The changeover should be undertaken under close medical supervision.</p><p>Special Populations</p><p>Patients with renal or hepatic impairment:</p><p>See section 4.3.</p><p>Children and adolescents:</p><p>There are no data available on the use of glimepiride in patients under 8 years of age. For children aged</p><p>8 to 17 years, there are limited data on glimepiride as monotherapy (see sections 5.1 and 5.2).</p><p>The available data on safety and efficacy are insufficient in the paediatric population and therefore such</p><p>use is not advised.</p><p><strong><em>Route of Administration</em></strong>:</p><p>Oral administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sequence SPC - 2
Glimepiride is contraindicated in patients with the following conditions:
• Hypersensitivity to glimepiride, other sulfonylureas or sulfonamides or to any of the excipients
• insulin dependent diabetes,
• diabetic coma,
• ketoacidosis,
• severe renal or hepatic function disorders. In case of severe renal or hepatic function disorders, a
change over to insulin is required.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glimepiride must be taken shortly before or during a meal. When meals are taken at irregular hours or</p><p>skipped altogether, treatment with Glimepiride may lead to hypoglycaemia. Possible symptoms of</p><p>hypoglycaemia include: headache, ravenous hunger, nausea, vomiting, lassitude, sleepiness, disordered</p><p>sleep, restlessness, aggressiveness, impaired concentration, alertness and reaction time, depression,</p><p>confusion, speech and visual disorders, aphasia, tremor, paresis, sensory disturbances, dizziness,</p><p>helplessness, loss of self-control, delirium, cerebral convulsions, somnolence and loss of</p><p>consciousness up to and including coma, shallow respiration and bradycardia. In addition, signs of</p><p>adrenergic counter-regulation may be present such as sweating, clammy skin, anxiety, tachycardia,</p><p>hypertension, palpitations, angina pectoris and cardiac arrhythmias. The clinical picture of a severe</p><p>hypoglycaemic attack may resemble that of a stroke. Symptoms can almost always be promptly</p><p>controlled by immediate intake of carbohydrates (sugar). Artificial sweeteners have no effect. It is</p><p>known from other sulfonylureas that, despite initially successful countermeasures, hypoglycaemia may</p><p>recur. Severe hypoglycaemia or prolonged hypoglycaemia, only temporarily controlled by the usual</p><p>amounts of sugar, require immediate medical treatment and occasionally hospitalisation.</p><p>Factors favouring hypoglycaemia include:</p><p>- Unwillingness or (more commonly in older patients) incapacity of the patient to cooperate,</p><p>- Undernutrition, irregular mealtimes or missed meals or periods of fasting,</p><p>- Alterations in diet,</p><p>- Imbalance between physical exertion and carbohydrate intake,</p><p>- Consumption of alcohol, especially in combination with skipped meals,</p><p>- Impaired renal function,</p><p>- Serious liver dysfunction,</p><p>- Overdosage with Glimepiride,</p><p>- Certain uncompensated disorders of the endocrine system affecting carbohydrate metabolism or</p><p>counterregulation of hypoglycaemia (as for example in certain disorders of thyroid function and in</p><p>anterior pituitary or adrenocortical insufficiency),</p><p>- Concurrent administration of certain other medicinal products.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Sequence SPC - 3</p><p>Treatment with Glimepiride requires regular monitoring of glucose levels in blood and urine. In</p><p>addition determination of the proportion of glycosylated haemoglobin is recommended.</p><p>Regular hepatic and haematological monitoring (especially leucocytes and thrombocytes) are required</p><p>during treatment with Glimepiride.</p><p>In stress-situations (e.g. accidents, acute operations, infections with fever, etc.) a temporary switch to</p><p>insulin may be indicated.</p><p>No experience has been gained concerning the use of Glimepiride in patients with severe impairment</p><p>of liver function or dialysis patients. In patients with severe impairment of renal or liver function</p><p>change over to insulin is indicated.</p><p>Treatment of patients with G6PD-deficiency with sulfonylurea agents can lead to hemolytic anaemia.</p><p>Since glimepiride belongs to the class of sulfonylurea agents, caution should be used in patients with</p><p>G6PD-deficiency and a non-sulfonylurea alternative should be considered.</p><p>Glimepiride contains lactose . Patients with rare hereditary problems of galactose intolerance, the Lapp</p><p>lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Many interactions have been reported with the sulfonylureas, largely representing either</p><p>pharmacokinetic interactions (due to the displacement of the antidiabetic from plasma proteins or</p><p>alteration in its metabolism since it is metabolized by Cytochrome P450 2 C9 (CYP2C9) or excretion)</p><p>or pharmacological interactions with drugs having an independent effect on blood glucose.</p><p>A diminished hypoglycaemic effect, possibly requiring an increased dose of sulfonylurea, has been</p><p>seen or might be expected on theoretical grounds with adrenaline and sympathomimetics ,</p><p>aminoglutethimide, chlorpromazine, corticosteroids, diazoxide, oral contraceptives (oestrogens and</p><p>progestogens), rifamycins, nicotinc acid and its derivatives, long term use of laxatives, phenytoin,</p><p>barbiturates, glucagon, acetazolamide, thiazide diuretics, and thyroid hormones and thyroid</p><p>stimulating agents.</p><p>An increased hypoglycaemic effect has occurred or might be expected with insulin , oral antidiabetics,</p><p>ACE inhibitors, alcohol, sympatholytics, allopurinol, probencid, disopyramide, fenfluramine, some</p><p>analgesics (notably azapropazone, phenylbutazone, oxyphenbutazone, p-aminosalicylic acid and the</p><p>salicylates), azole antifungals (fluconazole, ketoconazole, and miconazole), chloramphenicol,</p><p>cimetidine, clofibrate and related compounds, coumarin anticoagulants, clarithromycin,</p><p>fluoroquinolones, heparin, fluoxetine, MAOIs, phosphamides, , parentral high doses of pentoxipylline,</p><p>tritoqualine, octreotide (although this may also produce hyperglycaemia), ranitidine, anabolic steroids</p><p>a, male sex hormones, sulfinpyrazone, sulfonamides (including co-trimoxazole), tetracyclines, and</p><p>tricyclic antidepressants.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Sequence SPC - 4</p><p>H2 antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of</p><p>the blood glucose lowering effect.</p><p>Under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine</p><p>and reserpine, the signs of adrenergic counter-regulation to hypoglycaemia may be reduced or absent.</p><p>Alcohol intake may potentiate or weaken the hypoglycaemic action of glimepiride in an unpredictable</p><p>fashion.</p><p>Glimepiride may either potentiate or weaken the effects of coumarin derivatives.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy</p><p>Pregnancy risk factor C</p><p>Risk related to the diabetes</p><p>Abnormal blood glucose levels during pregnancy are related with a higher rate of congenital</p><p>abnormalities and perinatal mortality, so the blood glucose level must be closely monitored during</p><p>pregnancy in order to avoid the teratogenic possibility. The use of insulin is prefered under such</p><p>situation. Patients who consider pregnancy should notify their physician.</p><p>Risk related to glimepiride</p><p>There are no adequate data from the use of glimepiride in pregnant women. Animal studies have</p><p>shown reproductive toxicity which likely was related to the pharmacologic action (hypoglycaemia) of</p><p>glimepiride</p><p>Consequently, glimepiride should not be used during the whole pregnancy.</p><p>In case of treatment by glimepiride, if the patient plans to become pregnant or if a pregnancy is</p><p>discovered, the treatment should be switched as quickly as possible to insulin therapy.</p><p><em>Lactation</em></p><p>The excretion in human milk is unknown. Glimepiride is excreted in rat milk. As other sulfonylureas</p><p>are excreted in human milk and because there is a risk of hypoglycaemia in nursing infants, breastfeeding</p><p>is advised against during treatment with glimepiride.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Driving. In the UK, patients with diabetes mellitus treated with insulin or oral hypoglycaemics are</p><p>required to notify their condition to the Driver and Vehicle Licensing Agency, who then assess</p><p>their fitness to drive. Patients treated with oral hypoglycaemics are generally allowed to retain standard</p><p>driving licences; those treated with insulin receive restricted licences which must be renewed (with</p><p>appropriate checks) every 1 to 3 years. Patients should be warned of the dangers of hypoglycaemic</p><p>attacks while driving, and should be counselled in appropriate management of the situation (stopping</p><p>driving as soon as it is safe to do so, taking carbohydrate immediately, and quitting the driving seat and</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Sequence SPC - 5</p><p>removing the ignition key from the car) should such an event occur. Patients who have lost</p><p>hypoglycaemic awareness, or have frequent hypoglycaemic episodes, should not drive. In addition,</p><p>eyesight must be adequate (field of vision of at least 120&deg;) for a licence to be valid. Patients treated</p><p>with diet or oral hypoglycaemics are normally allowed to hold vocational driving licences for heavy</p><p>goods vehicles or passenger carrying vehicles; those treated with insulin may not drive such vehicles,</p><p>and are restricted in driving some other vehicles such as small lorries and minibuses.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastrointestinal disturbances such as nausea, vomiting, heartburn, anorexia, diarrhoea, and a metallic</p><p>taste may occur with sulfonylureas and are usually mild and dose-dependent; increased appetite and</p><p>weight gain may occur. Skin rashes and pruritus may occur and photosensitivity has been reported.</p><p>Rashes are usually hypersensitivity reactions and may progress to more serious disorders Other severe</p><p>effects may be manifestations of a hypersensitivity reaction. They include altered liver enzyme values,</p><p>hepatitis and cholestatic jaundice, leucopenia, thrombocytopenia, aplastic anaemia, agranulocytosis,</p><p>haemolytic anaemia, erythema multiforme or the Stevens- Johnson syndrome, exfoliative dermatitis,</p><p>and erythema nodosum</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After ingestion of an overdosage hypoglycaemia may occur, lasting from 12 to 72 hours, and may</p><p>recur after an initial recovery. Symptoms may not be present for up to 24 hours after ingestion. In</p><p>general observation in hospital is recommended. Nausea, vomiting and epigastric pain may occur. The</p><p>hypoglycaemia may in general be accompanied by neurological symptoms like restlessness, tremor,</p><p>visual disturbances, co-ordination problems, sleepiness, coma and convulsions. Treatment primarily</p><p>consists of preventing absorption by inducing vomiting and then drinking water or lemonade with</p><p>activated charcoal (adsorbent) and sodium-sulphate (laxative). If large quantities have been ingested,</p><p>gastric lavage is indicated, followed by activated charcoal and sodium-sulphate. In case of (severe)</p><p>overdosage hospitalisation in an intensive care department is indicated. Start the administration of</p><p>glucose as soon as possible, if necessary by a bolus intravenous injection of 50 ml of a 50% solution,</p><p>followed by an infusion of a 10% solution with strict monitoring of blood glucose. Further treatment</p><p>should be symptomatic.</p><p>In particular when treating hypoglycaemia due to accidental intake of Glimepiride in infants and young</p><p>children, the dose of glucose given must be carefully controlled to avoid the possibility of producing</p><p>dangerous hyperglycaemia. Blood glucose should be closely monitored.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC code: A10BB12.</p><p><strong>5.1 Pharmacodynamic properties</strong></p><p>Gimepiride is a orally active sulfonamides blood glucose lowering agent . It could be</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Sequence SPC - 6</p><p>prescribed for non-insulin dependent diabetes mellitus.</p><p>Sulfonylureas acts by stimulating insulin release from pancreatic beta cells mainly, this is</p><p>occurred an increase of responsiveness of the pancreatic beta cells to the physiological</p><p>glucose stimulus.</p><p>Glimepiride has pronounced extrapancreatic effects also postulated for other sulfonylureas.</p><p><em>Insulin release</em></p><p>Sulfonylureas regulate insulin secretion by closing the ATP-sensitive potassium channel in</p><p>the beta cell membrane. Closing the potassium channel induces depolarisation of the beta</p><p>cell and results - by opening of calcium channels - in an increased influx of calcium into the</p><p>cell which leads to insulin release through exocytosis.</p><p>Glimepiride binds with a high exchange rate to a beta cell membrane protein which is</p><p>associated with the ATP-sensitive potassium channel but which is different from the usual</p><p>sulfonylurea binding site.</p><p><em>Extrapancreatic activity</em></p><p>The extrapancreatic effects are for example an improvement of the sensitivity of the</p><p>peripheral tissue for insulin and a decrease of the insulin uptake by the liver.</p><p>The uptake of glucose from blood into peripheral muscle and fat tissues occurs via special</p><p>transport proteins, located in the cells membrane. The transport of glucose in these tissues</p><p>is the rate limiting step in the use of glucose. Glimepiride increases very rapidly the number</p><p>of active glucose transport molecules in the plasma membranes of muscle and fat cells,</p><p>resulting in stimulated glucose uptake.</p><p>Glimepiride increases the activity of the glycosyl-phosphatidylinositol-specific</p><p>phospholipase C which may be correlated with the drug-induced lipogenesis and</p><p>glycogenesis in isolated fat and muscle cells.</p><p>Glimepiride inhibits the glucose production in the liver by increasing the intracellular</p><p>concentration of fructose-2, 6-bisphosphate, which in its turn inhibits the gluconeogenesis.</p><p><em>General</em></p><p>In healthy persons, the minimum effective oral dose is approximately 0.6 mg. The effect of</p><p>glimepiride is dose-dependent and reproducible. The physiological response to acute</p><p>physical exercise, reduction of insulin secretion, is still present under glimepiride.</p><p>There was no significant difference in effect regardless of whether the medicinal product</p><p>was given 30 minutes or immediately before a meal. In diabetic patients, good metabolic</p><p>control over 24 hours can be achieved with a single daily dose.</p><p>Although the hydroxy metabolite of glimepiride caused a small but significant decrease in</p><p>serum glucose in healthy persons, it accounts for only a minor part of the total drug effect.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Sequence SPC - 7</p><p><em>Combination therapy with metformin</em></p><p>Improved metabolic control for concomitant glimepiride therapy compared to metformin</p><p>alone in patients not adequately controlled with the maximum dosage of metformin has</p><p>been shown in one study.</p><p><em>Combination therapy with insulin</em></p><p>Data for combination therapy with insulin are limited. In patients not adequately controlled</p><p>with the maximum dosage of glimepiride, concomitant insulin therapy can be initiated. In</p><p>two studies, the combination achieved the same improvement in metabolic control as</p><p>insulin alone; however, a lower average dose of insulin was required in combination</p><p>therapy.</p><p>Special populations</p><p><em>Children and adolescents</em></p><p>An active controlled clinical trial (glimepiride up to 8 mg daily or metformin up to 2,000 mg</p><p>daily) of 24 weeks duration was performed in 285 children (8-17 years of age) with type 2</p><p>diabetes.</p><p>Both glimepiride and metformin exhibited a significant decrease from baseline in HbA1c</p><p>(glimepiride -0.95 (se 0.41); metformin -1.39 (se 0.40)). However, glimepiride did not</p><p>achieve the criteria of non-inferiority to metformin in mean change from baseline of HbA1c.</p><p>The difference between treatments was 0.44% in favour of metformin. The upper limit</p><p>(1.05) of the 95% confidence interval for the difference was not below the 0.3% noninferiority</p><p>margin.</p><p>Following glimepiride treatment, there were no new safety concerns noted in children</p><p>compared to adult patients with type 2 diabetes mellitus. No long-term efficacy and safety</p><p>data are available in paediatric patients</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glimepiride is completely absorbed from the gastrointestinal tract. Peak plasma concentrations occur</p><p>in 2 to 3 hours, and it is highly protein bound. The drug is extensively metabolised to two main</p><p>metabolites, a hydroxy derivative and a carboxy derivative. The half-life after multiple doses is about 9</p><p>hours. About 60% of a dose is eliminated in the urine and 40% in the faeces.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Sequence SPC - 8</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical effects observed occurred at exposures sufficiently in excess of the maximum human</p><p>exposure as to indicate little relevance to clinical use, or were due to the pharmacodynamic action</p><p>(hypoglycaemia) of the compound. This finding is based on conventional safety pharmacology,</p><p>repeated dose toxicity, genotoxicity, carcinogenicity, and reproduction toxicity studies. In the latter</p><p>(covering embryotoxicity, teratogenicity and developmental toxicity), adverse effects observed were</p><p>considered to be secondary to the hypoglycaemic effects induced by the compound in dams and in</p><p>offspring.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glimepiride 1 tablets contains iron oxide red, Glimepiride 2 tablets contains iron oxide yellow and</p><p>Blue lake No. 2, Glimepiride 3 tablets contains iron oxide yellow and Glimepiride 4 tablets contains</p><p>Blue lake No. 2.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30 degree.</p><p>S.No. Materials</p><p>1. Lactose</p><p>2. Sodium Starch Glycolate</p><p>3. Povidone</p><p>4. Sodium Lauryl Sulphate</p><p>5. Magnesium Stearate</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glimepiride 1 tablets : box contains 3 strips, each of 10 tablets (transparent PVDC/Aluminum</p><p>blisters).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DEEF Pharmaceutical Industries Co. Ltd
P.O Box 6 , Badaye, Qassim 51951, Saudi Arabia
Manufactured by: DEEF Pharmaceutical Industries Co. Ltd, Saudi Arabia

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                May 2011
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>